SPY332.11+2.05 0.62%
DIA272.00+3.59 1.34%
IXIC10,998.40+57.23 0.52%

Biogen shares are trading higher after analysts at Morgan Stanley upgraded their rating of the stock to Overweight and raised their price to $357.

Benzinga · -